Over 200 million Americans are covered by private health insurance, yet one in seven claims for treatment are denied. The ...

It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Microscopic colitis, a form of inflammatory bowel disease, has no cure, but it's possible to enter remission. Learn more here ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.